Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fineman

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Clinical and Experimental Rheumatology|January 14, 2025
A Phase 3, 56-week, randomised, double-blind, placebo-controlled study (OA-11) utilising patient-reported and radiographic outcomes evaluating the efficacy and safety of a lorecivivint injection in patients with moderate to severe knee osteoarthritisYusuf Yazici, Jeyanesh R S Tambiah, Christopher J Swearingen, et al.
Ophthalmology|November 1, 2006
Pars plana vitrectomy versus combined pars plana vitrectomy-scleral buckle for primary repair of pseudophakic retinal detachmentEric D Weichel, Adam Martidis, Mitchell S Fineman, et al.
Rheumatology and Therapy|October 30, 2023
Safety, Tolerability, and Pharmacokinetics of Same-Knee Intra-Articular Injection of Corticosteroid and Lorecivivint Within 7 Days: An Open-Label, Randomized, Parallel-Arm StudyMark S Fineman, Timothy E McAlindon, Christian Lattermann, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|October 12, 2011
Ranibizumab for eyes previously treated with pegaptanib or bevacizumab without clinical responseRichard S Kaiser, Omesh P Gupta, Carl D Regillo, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 22, 1998
Joint Task Force Algorithm and Annotations for Diagnosis and Management of RhinitisM S Dykewicz, S Fineman, R Nicklas, et al.
Retina (Philadelphia, Pa.)|November 28, 2007
Intravitreal bevacizumab (avastin) in central retinal vein occlusionJason Hsu, Richard S Kaiser, Arunan Sivalingam, et al.
Clinical and Experimental Rheumatology|January 14, 2025
A Phase 3, 28-week, multicentre, randomised, double-blind, placebo-controlled trial (OA-10) to evaluate the efficacy and safety of a single injection of lorecivivint in the target knee joint of moderately to severely symptomatic osteoarthritis patientsYusuf Yazici, Jeyanesh R S Tambiah, Christopher J Swearingen, et al.
Ophthalmology|March 3, 2015
Speculum versus Bimanual Lid Retraction during Intravitreal InjectionEhsan Rahimy, Mitchell S Fineman, Carl D Regillo, et al.
The Journal of Clinical Endocrinology and Metabolism|September 8, 2005
Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetesFrauke Fehse, Michael Trautmann, Jens J Holst, et al.
Retinal Cases & Brief Reports|August 16, 2022
NODULAR EPIRETINAL MÜLLER CELL GLIOSIS IN THE FOVEAJesse J Jung, Anne Zeng, Rahul Komati, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Clinical and Experimental Rheumatology|January 14, 2025
A Phase 3, 56-week, randomised, double-blind, placebo-controlled study (OA-11) utilising patient-reported and radiographic outcomes evaluating the efficacy and safety of a lorecivivint injection in patients with moderate to severe knee osteoarthritisYusuf Yazici, Jeyanesh R S Tambiah, Christopher J Swearingen, et al.
Ophthalmology|November 1, 2006
Pars plana vitrectomy versus combined pars plana vitrectomy-scleral buckle for primary repair of pseudophakic retinal detachmentEric D Weichel, Adam Martidis, Mitchell S Fineman, et al.
Rheumatology and Therapy|October 30, 2023
Safety, Tolerability, and Pharmacokinetics of Same-Knee Intra-Articular Injection of Corticosteroid and Lorecivivint Within 7 Days: An Open-Label, Randomized, Parallel-Arm StudyMark S Fineman, Timothy E McAlindon, Christian Lattermann, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|October 12, 2011
Ranibizumab for eyes previously treated with pegaptanib or bevacizumab without clinical responseRichard S Kaiser, Omesh P Gupta, Carl D Regillo, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 22, 1998
Joint Task Force Algorithm and Annotations for Diagnosis and Management of RhinitisM S Dykewicz, S Fineman, R Nicklas, et al.
Retina (Philadelphia, Pa.)|November 28, 2007
Intravitreal bevacizumab (avastin) in central retinal vein occlusionJason Hsu, Richard S Kaiser, Arunan Sivalingam, et al.
Clinical and Experimental Rheumatology|January 14, 2025
A Phase 3, 28-week, multicentre, randomised, double-blind, placebo-controlled trial (OA-10) to evaluate the efficacy and safety of a single injection of lorecivivint in the target knee joint of moderately to severely symptomatic osteoarthritis patientsYusuf Yazici, Jeyanesh R S Tambiah, Christopher J Swearingen, et al.
Ophthalmology|March 3, 2015
Speculum versus Bimanual Lid Retraction during Intravitreal InjectionEhsan Rahimy, Mitchell S Fineman, Carl D Regillo, et al.
The Journal of Clinical Endocrinology and Metabolism|September 8, 2005
Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetesFrauke Fehse, Michael Trautmann, Jens J Holst, et al.
Retinal Cases & Brief Reports|August 16, 2022
NODULAR EPIRETINAL MÜLLER CELL GLIOSIS IN THE FOVEAJesse J Jung, Anne Zeng, Rahul Komati, et al.
Pageof 11